CYB5R3 anticorps
Aperçu rapide pour CYB5R3 anticorps (ABIN2718916)
Antigène
Voir toutes CYB5R3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens cytochrome b5 reductase 3 (CYB5R3), transcript variant 1
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human CYV5R3(NP_000389) produced in HEK293T cell.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- WB 1:500~2000, IHC 1:150, IF 1:100,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- CYB5R3 (Cytochrome B5 Reductase 3 (CYB5R3))
-
Autre désignation
- CYB5R3
-
Sujet
- This gene encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. The membrane-bound form exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism. The erythrocyte form is located in a soluble fraction of circulating erythrocytes and is involved in methemoglobin reduction. The membrane-bound form has both membrane-binding and catalytic domains, while the soluble form has only the catalytic domain. Alternate splicing results in multiple transcript variants. Mutations in this gene cause methemoglobinemias.
-
Poids moléculaire
- 34.1 kDa
-
ID gène
- 1727
-
NCBI Accession
- NM_000398
-
HGNC
- 1727
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-